Randomized phase II/III clinical trial of elpamotide for patients with advanced pancreatic cancer: PEGASUS‐PC Study

E-ISSN： 1349-7006|106|7|883-890

ISSN： 1347-9032

Source： Cancer Science, Vol.106, Iss.7, 2015-07, pp. : 883-890

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase I/II trial of chemoradiotherapy with concurrent S‐1 and cisplatin for clinical stage II/III esophageal carcinoma (JCOG 0604)

Cancer Science, Vol. 106, Iss. 10, 2015-10 ,pp. : 1414-1420

John Wiley & Sons Inc

Access to resources Recommend Favorite

Phase II trial of chemoradiotherapy with S‐1 plus cisplatin for unresectable locally advanced head and neck cancer (JCOG0706)

Cancer Science, Vol. 106, Iss. 6, 2015-06 ,pp. : 726-733

John Wiley & Sons Inc

Access to resources Recommend Favorite

Open‐label, randomized, comparative, phase III study on effects of reducing steroid use in combination with Palonosetron

Cancer Science, Vol. 106, Iss. 7, 2015-07 ,pp. : 891-895

John Wiley & Sons Inc

Access to resources Recommend Favorite

Phase I study of tivantinib in Japanese patients with advanced hepatocellular carcinoma: Distinctive pharmacokinetic profiles from other solid tumors

Cancer Science, Vol. 106, Iss. 5, 2015-05 ,pp. : 611-617

John Wiley & Sons Inc

Access to resources Recommend Favorite

Phase I study of single‐agent ribociclib in Japanese patients with advanced solid tumors

Cancer Science, Vol. 109, Iss. 1, 2018-01 ,pp. : 193-198

John Wiley & Sons Inc

Access to resources Recommend Favorite